These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1100310)

  • 41. Evaluation of the effects of pefloxacin on platelet aggregation in vitro and ex vivo in patients suffering from chronic bronchitis.
    Cazzola M; Santangelo G; Angrisani M; Vinciguerra A; Contaldi C; Rossi F
    J Chemother; 1995 Feb; 7(1):38-41. PubMed ID: 7629557
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of lomefloxacin and sparfloxacin on human platelet aggregation.
    Losasso C; Loffreda A; Angrisani M; Contaldi C; Cazzola M; Rossi F
    J Chemother; 1995 Oct; 7(5):420-3. PubMed ID: 8596124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of platelet aggregation in man by indobufen (K 3920).
    Vittoria A; Laghi Pasini F; Messa GL; Di Perri T; Corvi G; Fuccella LM
    J Int Med Res; 1981; 9(1):12-7. PubMed ID: 7202826
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of ketotifen and disodium cromoglycate on human platelet aggregation.
    García Mesa M; Arruzazabala Valmaña ML
    Allergol Immunopathol (Madr); 1989; 17(1):33-4. PubMed ID: 2502003
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Platelet inhibitory activity and pharmacokinetics of prasugrel (CS-747) a novel thienopyridine P2Y12 inhibitor: a single ascending dose study in healthy humans.
    Asai F; Jakubowski JA; Naganuma H; Brandt JT; Matsushima N; Hirota T; Freestone S; Winters KJ
    Platelets; 2006 Jun; 17(4):209-17. PubMed ID: 16769598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pyrrolo[3,2-c]pyridine derivatives as inhibitors of platelet aggregation.
    Altomare C; Summo L; Cellamare S; Varlamov AV; Voskressensky LG; Borisova TN; Carotti A
    Bioorg Med Chem Lett; 2000 Mar; 10(6):581-4. PubMed ID: 10741558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin.
    Wong PC; Jiang X
    Thromb Haemost; 2010 Aug; 104(2):302-10. PubMed ID: 20589316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The in vitro effect of ticlopidine on fibrinogen and factor VIII binding to human platelets.
    Lee H; Paton RC; Ruan C; Caen JP
    Thromb Haemost; 1981 Oct; 46(3):590-2. PubMed ID: 6797089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative study of platelet aggregation measured with 3 different methods (photometric and impedance) in ticlopidine treated patients.
    Lecrubier C; Girard P; Noire P; Samama M
    Agents Actions Suppl; 1984; 15():60-7. PubMed ID: 6592946
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparison between the antiaggregating effect of ticlopidine in whole blood, platelet-rich plasma and washed platelets of the rat.
    Randon J; Lefort J; Vargaftig BB
    Thromb Res; 1982 Apr; 26(1):13-20. PubMed ID: 7048623
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased active metabolite formation explains the greater platelet inhibition with prasugrel compared to high-dose clopidogrel.
    Payne CD; Li YG; Small DS; Ernest CS; Farid NA; Jakubowski JA; Brandt JT; Salazar DE; Winters KJ
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):555-62. PubMed ID: 18030066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short-term inhibition of ADP-induced platelet aggregation by clopidogrel ameliorates radiation-induced toxicity in rat small intestine.
    Wang J; Albertson CM; Zheng H; Fink LM; Herbert JM; Hauer-Jensen M
    Thromb Haemost; 2002 Jan; 87(1):122-8. PubMed ID: 11848440
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Collagen-induced platelet aggregation: the role of adenine nucleotides and the release reaction.
    Kattlove H; Gomez MH
    Thromb Diath Haemorrh; 1975 Dec; 34(3):795-805. PubMed ID: 813326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ticlopidine and platelet function.
    Lecompte T; Lecrubier C; Potevin F; Samama M
    Thromb Haemost; 1986 Jun; 55(3):437-8. PubMed ID: 3529484
    [No Abstract]   [Full Text] [Related]  

  • 55. [Evaluation of the effect of picotamide on platelet function in diabetic subjects].
    Carleo R; Veno L; Fuccio F; Bonavita M; De Matteo A; Gallo M; Gatti A; Gobbo M; Nocerino L
    Boll Soc Ital Biol Sper; 1990 Jul; 66(7):647-54. PubMed ID: 2083059
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [State of adhesive-aggregative function of platelets in patients with systemic lupus erythematosus].
    Shevchuk SV
    Lik Sprava; 2007; (1-2):27-32. PubMed ID: 17684802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of recurrent cerebral infarction with adenosine diphosphate- and collagen-induced platelet aggregation in patients treated with ticlopidine and/or aspirin.
    Abumiya T; Houkin K
    J Stroke Cerebrovasc Dis; 2011; 20(4):319-23. PubMed ID: 20634093
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of platelet aggregation by bisulfite-sulfite.
    Kikugawa K; Iizuka K
    J Pharm Sci; 1972 Dec; 61(12):1904-7. PubMed ID: 4638095
    [No Abstract]   [Full Text] [Related]  

  • 59. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bicyclic thiophenic derivatives as platelet aggregation inhibitors.
    Darias V; Bravo L; Fraile C; Martin-Herrera D; Corral C; Lissavetzky J
    Farmaco Sci; 1986 Jun; 41(6):478-82. PubMed ID: 3743742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.